Status:

COMPLETED

Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

Lead Sponsor:

Centre Oscar Lambret

Conditions:

Breast Cancer

Eligibility:

FEMALE

18-70 years

Phase:

PHASE3

Brief Summary

RATIONALE: Estrogen can cause the growth of breast cancer cells. Aromatase inhibitors, such as letrozole, anastrozole, and exemestane, may fight breast cancer by lowering the amount of estrogen the bo...

Detailed Description

OBJECTIVES: Primary * To evaluate verbal episodic memory in patients with breast cancer after 6 months of treatment with aromatase inhibitors (AI) vs tamoxifen citrate. Secondary * To evaluate cog...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed breast cancer
  • No metastatic disease
  • Meets criteria for initiating adjuvant endocrine therapy
  • Hormone receptor status:
  • Estrogen receptor- and/or progesterone receptor-positive disease
  • PATIENT CHARACTERISTICS:
  • Postmenopausal, defined as no menstruation for ≥ 1 year, confirmed by a measurement of FSH and 17-beta-estradiol
  • Karnofsky performance status 80-100%
  • Native speaker of French
  • Beneficiary of a French Social Security insurance plan
  • No prior cognitive disorders
  • No depression or other confirmed active psychiatric disease
  • Able to undergo the medical monitoring of the trial due to geographic, social or psychological reasons
  • No personal or family history of thromboembolic disease
  • PRIOR CONCURRENT THERAPY:
  • No prior adjuvant chemotherapy
  • No concurrent follow-up participation on another study
  • No concurrent treatment with psychotropic substances (i.e., long half life benzodiazepines, antipsychotics, anticholinesterase)

Exclusion

    Key Trial Info

    Start Date :

    March 16 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 26 2014

    Estimated Enrollment :

    44 Patients enrolled

    Trial Details

    Trial ID

    NCT00893061

    Start Date

    March 16 2009

    End Date

    November 26 2014

    Last Update

    June 14 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Centre Oscar Lambret

    Lille, France, 59020

    2

    Centre Eugene Marquis

    Rennes, France

    3

    Centre Paul Strauss

    Strasbourg, France

    Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer | DecenTrialz